Chengwei Chen
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial.
Journal: Hepatology international
Published: January 04, 2026
Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study.
Journal: Journal of gastroenterology and hepatology
Published: December 20, 2025
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China.
Journal: Journal of clinical and translational hepatology
Published: August 26, 2025
Drug-induced liver injury in children: A nationwide cohort study from China.
Journal: JHEP reports : innovation in hepatology
Published: November 08, 2023
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients.
Journal: Journal of clinical and translational hepatology
Published: September 15, 2023
Hydronidone for the Treatment of Liver Fibrosis Related to Chronic Hepatitis B: A Phase 2 Randomized Controlled Trial.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 24, 2022
Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: A multicenter, randomized, phase II trial.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 21, 2021
Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database.
Journal: The Journal of international medical research
Published: April 15, 2021
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China.
Journal: Journal of clinical and translational hepatology
Published: December 01, 2020
Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial.
Journal: BMC gastroenterology
Published: January 14, 2020
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China.
Journal: Journal of clinical and translational hepatology
Published: July 30, 2019
Last Updated: 09/26/2026